Functional Assessment of Cancer Therapy Questionnaire for Breast Cancer (FACT-B+4). Spanish version validation

被引:32
作者
Belmonte Martinez, Roser [1 ,2 ]
Garin Boronat, Olatz [3 ,4 ]
Segura Badia, Marcel [5 ]
Sanz Latiesas, Javier [6 ]
Marco Navarro, Ester [1 ]
Ferrer Fores, Montserrat [3 ,4 ,7 ]
机构
[1] Hosp Mar Esperanca, Serv Med Fis & Rehabil, Barcelona, Spain
[2] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain
[3] Recerca Hosp Mar, IMIM Inst, Barcelona, Spain
[4] CIBERESP, Madrid, Spain
[5] Hosp Mar Esperanca, Serv Cirurgia Gen & Aparell Digestiu, Barcelona, Spain
[6] Hosp Mar Esperanca, Serv Oncol Radioterap, Barcelona, Spain
[7] Univ Autonoma Barcelona, Dept Pediat Obstet & Ginecol & Med Prevent, E-08193 Barcelona, Spain
来源
MEDICINA CLINICA | 2011年 / 137卷 / 15期
关键词
Breast cancer; Lymphedema; Quality of life; RELIABILITY; POPULATION; SCALE; SF-36;
D O I
10.1016/j.medcli.2010.11.028
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: To evaluate the acceptability, reliability, validity, and sensitivity to change of the Spanish version of the FACT-B+4 questionnaire, designed to assess the health related quality of life (HRQL) in breast cancer. Patients and methods: Prospective study with 2 samples: patients with incident breast cancer (n = 104) evaluated before and after surgery; and patients with chronic lymphedema of the upper extremity (n = 30), evaluated twice in 7 days. HRQL was assessed using the generic instrument SF-36 and the specific one FACT-B+4. Results: Reliability coefficients were >= 0.7 for most scores. The Physical wellbeing, Breast Cancer, Arm and TOI scores discriminated between patients with and without chemotherapy (p < 0.05). while the Arm scale discriminated between patients with and without axillary surgery (p < 0.001). In the worsening sub-sample, the FACT-B+4 detected changes in Physical, Emotional and Functional Wellbeing, and TOI scores. Conclusions: The metric characteristics of the Spanish version of the FACT-B+4 are similar to the original questionnaire and support its equivalence, documenting its suitability for use in our country or in international studies. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:685 / 688
页数:4
相关论文
共 9 条
[1]  
Alonso J, 1998, MED CLIN-BARCELONA, V111, P410
[2]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[3]   Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument [J].
Brady, MJ ;
Cella, DF ;
Mo, F ;
Bonomi, AE ;
Tulsky, DS ;
Lloyd, SR ;
Deasy, S ;
Cobleigh, M ;
Shiomoto, G .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :974-986
[4]   Patient-reported outcomes in a phase III, randomized study of sunitinib versus interferon-α as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population [J].
Castellano, D. ;
Garcia del Muro, X. ;
Perez-Gracia, J. L. ;
Gonzalez-Larriba, J. L. ;
Abrio, M. V. ;
Ruiz, M. A. ;
Pardo, A. ;
Guzman, C. ;
Diaz Cerezo, S. ;
Grande, E. .
ANNALS OF ONCOLOGY, 2009, 20 (11) :1803-1812
[5]   The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively [J].
Coster, S ;
Poole, K ;
Fallowfield, LJ .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (03) :273-282
[6]   A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale [J].
Eton, DT ;
Cella, D ;
Yost, KJ ;
Yount, SE ;
Peterman, AH ;
Neuberg, DS ;
Sledge, GW ;
Wood, WC .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (09) :898-910
[7]  
Prieto L, 1998, MED CLIN-BARCELONA, V110, P142
[8]   The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study [J].
Sprangers, MAG ;
Groenvold, M ;
Arraras, JI ;
Franklin, J ;
teVelde, A ;
Muller, M ;
Franzini, L ;
Wiliams, A ;
deHaes, HCJM ;
Hopwood, P ;
Cull, A ;
Aaronson, NK .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2756-2768
[9]   Interpretation of SF-36 and SF-12 questionnaires in Spain:: physical and mental components [J].
Vilagut, Gernma ;
Maria Valderas, Jose ;
Ferrer, Montserrat ;
Garin, Olatz ;
Lopez-Garcia, Esther ;
Alonso, Jordi .
MEDICINA CLINICA, 2008, 130 (19) :726-735